Hyderabad, Feb.1 (RAHNUMA): Confederation of Indian Industry (CII), Telangana, organised the seminar on “Sustainable Pharma Manufacturing and Green Chemistry” at CII Green Business Centre in Hyderabad.
The seminar brought together key stakeholders to explore sustainable manufacturing and green chemistry in pharma and chemicals, with a focus on efficiency, safety, regulatory compliance, and environmental responsibility.
It highlighted best practices and reinforced industry commitment to cleaner, safer, and more resilient manufacturing.
The seminar’s inaugural session was addressed by prominent industry leaders from Pharma & Lifesciences sector in Telangana.
Chief Guest of the seminar Dr Sarvesh Singh, Director & CEO, Telangana Lifesciences, Govt of Telangana, said that Green Chemistry not only focuses on responsible supply chains, clean operations and how future ready are our operations but also how cost efficient and safer the operations are and fast regulatory approvals.
All stakeholders need to work together in building worldclass organizations. India has to move from volume leadership to value leadership and sustainability will drive this.
Ch. Rameswara Rao, National President, Bulk Drug’s Manufacturers Association & Chairman & MD, Rakshit group of Pharmaceutical Companies, in his address said that Telangana is known as Bulk Drugs manufacturing hub.
“We have more than 250 MSME companies which are into bulk drugs manufacturing. Large scale companies have started implementing green chemistry but MSMEs are slow to adopt due to high initial costs. The State Government could build shared infrastructure like bulk drugs manufacturing parks which could support in solvents recovery/ recycling and reduce the pollution load in the operations and reduce the transaction cost. Large companies should support MSMEs in adoption of green chemistry,” he said.
Dr. Narendran, Deputy Drugs Controller (India), Central Drugs Standard Control Organisation (CDSCO) said that Green synthesis intervention introduces eco-friendly methods into a synthesis process to reduce environmental and health impacts.
This approach minimises the usage of hazardous chemicals and reduces the solvents usage. Regulatory authorities focus on balancing environmental goals while achieving patient safety, validating new green processes without compromising the quality which ensuring that the companies follow global environmental standards, he said.
Raja Bhanu, Director General, Pharmaceuticals Export Promotion Council of India, mentioned that this year’s World Economic Forum focused mostly on need for further strengthening sustainability.
In the recent years, India has emerged as global supplier of affordable and accessible medicines of the world. India’s Pharma exports have crossed $30.4 billion while registering 9.4% annual growth rate which exporting to around 190-200 countries, he said.
Deepak Sapra, CEO (API and Services), Dr Reddy’s Laboratories Ltd, in his address said that sustainability means not only adhering to regulatory authorities, meeting customers audits but it positively impacts the people’s health and planet.
Dr. Anand Kumar, Advisor- CII Telangana Pharma & Life Sciences Panel & Managing Director, Indian Immunologicals Ltd, said that scientific and industrial innovation must go hand-in-hand with environmental responsibility.
